Please Wait
Applying Filters...
menu
    • menu
    Kewpie-PSE
    News
    Consolidated business results for fiscal year ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Supplementary Data for the FY Ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Notice regarding Formulation of Medium-Term Business Plan

    25 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Kewpie Corporation

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/a9474wUfYEQ
    Menu

    Kewpie Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Hyaluronic Acid

    02 1Sodium Hyaluronate

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hyaluronic Acid

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers de...
    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers derivatives as per client needs. Kewpie exports to over 30 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Kewpie Company Banner

    01

    Hyaluronic Acid

    Japan
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Kewpie Corporation

    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers derivatives as per client needs. Kewpie exports to over 30 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and exte...

    Kewpie Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Sodium Hyaluronate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers de...
    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers derivatives as per client needs. Kewpie exports to over 30 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Kewpie Company Banner

    02

    Sodium Hyaluronate

    Japan
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Kewpie Corporation

    Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and external preparations, manufactured near Tokyo under strict regulations. Since 2016, Kewpie also produces medical devices using Sodium hyaluronate and offers derivatives as per client needs. Kewpie exports to over 30 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Kewpie, the leading Japanese manufacturer of pharmaceutical-grade Sodium hyaluronate, first developed it in 1983. Its products are used as APIs and excipients for injections, eye drops, and exte...

    Kewpie Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Kewpie Corporation and get a quotation

    Kewpie Corporation is a supplier offers 5 products (APIs, Excipients or Intermediates).

    Find a price of Sodium Hyaluronate bulk with DMF, CEP, JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with DMF, JDMF offered by Kewpie Corporation

    Find a price of Hyaluronic Acid bulk with JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk offered by Kewpie Corporation

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.